Implications for Compounding Pharmacies and Prescribers (and Outsourcing Facilities) The April 1 clarification, read alongside FDA's escalating enforcement posture since early 2026, may signal a maturing and increasingly restrictive regulatory environment for GLP-1 compounding
This suggests that adjusting to lifestyle changes which can affect hydration, blood sugar, and energy levels may also contribute to headaches while youre trying to lose weight
Retatrutide is a novel peptide that interacts with multiple hormone receptors involved in metabolic regulation
This development aligns closely with Formycon's strategy
Non-pharmacological interventions include: Structured diabetes self-management education programmes (such as DESMOND or X-PERT) addressing foot care, injury prevention, and self-monitoring Podiatry services for nail care, callus management, and orthotic provision Physiotherapy to address gait abnormalities and reduce fall risk Psychological support for chronic pain management Foot protection is paramount for patients with sensory loss